Sangel Biomedical Venture Capital

Sangel Biomedical Venture Capital

Shenzen based venture capital firm investing in biotechnology companies in China and abroad.

Sangel Biomedical Venture Capital is a Shenzen based venture capital firm investing in biotechnology companies in China and abroad. It was established in 2010 to support high-tech enterprises in China and western countries. The company focuses on biomedicine, medical devices, healthcare, pharmaceutical, and livelihood security. In 2015, Sangel started its first international subsidiary, Sangel Venture Capital Corp in Chicago, United States. As of 2019, the company has made 16 investments in 15 portfolio companies with one successful exit.

Timeline

Funded Companies

Company
Description
Industry
Website
Location
Sirnaomics

A biopharmaceutical company developing RNA interference-based therapeutics for human diseases

Venture funded nanopore technology company.

2 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.